Concerning N-(n-propyl) ajmaline bromide or bitartrate, a water soluble derivative of ajmaline, several reports have been published on the toxicity and antiarrhythmic effect on either experimental or clinical arrhythmias. Gendenshtein (1, 2) demonstrated that the mode of antiarrhythmic effect of N-propyl ajmaline bromide for auricular and ventricular arrhythmias induced either by electrical stimulation, or by drugs such as aconitine, acetylcholine, ouabain and calcium chloride in rats and dogs was similar to that of ajmaline but was Approx. ten times more effective and four to eight times more toxic in mice and guinea-pigs. Philipsborn (3), Weidner and Philipsborn (4) reported that bitartrate of N-propyl ajmaline was five to six times more effective on aconitine-induced arrhythmia in rats but five or six times more toxic than ajmaline. In previous papers the authors suggested that ajmaline would be a most authentic antiarrhythmic compound as almost the same effective dose was obtained for different kinds of experimental arrhythmia and by different procedures of administration (5, 6).
Concerning N-(n-propyl) ajmaline bromide or bitartrate, a water soluble derivative of ajmaline, several reports have been published on the toxicity and antiarrhythmic effect on either experimental or clinical arrhythmias. Gendenshtein (1, 2) demonstrated that the mode of antiarrhythmic effect of N-propyl ajmaline bromide for auricular and ventricular arrhythmias induced either by electrical stimulation, or by drugs such as aconitine, acetylcholine, ouabain and calcium chloride in rats and dogs was similar to that of ajmaline but was Approx. ten times more effective and four to eight times more toxic in mice and guinea-pigs. Philipsborn (3), Weidner and Philipsborn (4) reported that bitartrate of N-propyl ajmaline was five to six times more effective on aconitine-induced arrhythmia in rats but five or six times more toxic than ajmaline. In previous papers the authors suggested that ajmaline would be a most authentic antiarrhythmic compound as almost the same effective dose was obtained for different kinds of experimental arrhythmia and by different procedures of administration (5, 6) .
In this study antiarrhythmic activities of N-propyl ajmaline bitartrate were evaluated on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
METHODS
Experiments were performed on mongrel dogs of both sexes weighing 9 to 15 kg. Animals were anesthetized with pentobarbital sodium, 30 mg/kg i.v. In order to induce atrial arrhythmia, a cup method was used which was developed by the authors instead of the given by the titration procedure. HR, heart rate ; SBP, systemic blood pressure and ECG (lead II). given at 15 min intervals until ventricular arrhythmia developed. Supramaximal electrical stimulation of the right vagal nerve did not affect the arrhythmia when it was fully developed (8).
Test compounds were infused intravenously. Infusion was interrupted when the normal sinus rhythm was restored and the duration of antiarrhythmic activity was determined. Criteria of antiarrhythmic activity has been previously described (5, 6 ). Student's t-test was carried out for statistical analysis of the results. A) HR, heart rate; b) SBP, systolic blood pressure at the femoral artery; c) DBP; diastolic blood pressure at the femoral artery; d) NS, statistically not significant difference from control; e) Data were reported previously by the present authors in Experientia 27, 666 (1971), f) After i.v. administration of 10 mg/kg, g) Statistically different from control (p<0.05).
EFFECT
OF N-PROPYL AJMALINE 13 flutter occurred initially and then sudden cardiac arrest (Table 3) . Prior treatment with blocking agent CS-359 (5-methyl-8 (2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (9, 10) fully abolished the incidents of ventricular flutter or fibrillation produced by rapid infusion of N-propyl ajmaline in four dogs (Table 3) . Typical data is illustrated in Fig. 4 . 
